Image

Understanding Chronic Treatments by Patients Over 65 Years of Age

Understanding Chronic Treatments by Patients Over 65 Years of Age

Recruiting
65 years and older
All
Phase N/A

Powered by AI

Overview

The ageing of the French population is accompanied by an increase in the number of chronic conditions per person. In 2008, according to IRDES (Institute for Research and Documentation in Health Economics), the average number of reported illnesses was six for people over the age of 65.

This multi-morbidity is associated with polypharmacy, which is a recognised risk factor for poor treatment compliance.

One of the causes of poor compliance is a lack of understanding of the treatment. In this context, the role of the general practitioner is central. General practitioners are responsible for more than three-quarters of medical prescriptions. They are the ones who initiate first-line treatments for chronic diseases, but also the ones who renew treatments introduced by specialists.

Description

Objectives Primary: To describe the understanding of chronic treatments by patients over 65 years of age.

Secondary: To investigate the factors associated with the understanding of chronic treatments by patients over 65 years of age.

Eligibility

Inclusion Criteria:

  • Are aged 65 or over
  • Consulting one of the general practitioners agreeing to participate in the study
  • Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months)
  • Agree to participate in the study.

Exclusion Criteria:

  • Does not understand French,
  • Has neurocognitive disorders
  • Lives in a medical facility
  • Consulting for an acute condition and whose prescription does not include chronic treatment.
  • Protected by law (guardianship, curatorship, judicial protection),

Study details
    Chronic Treatments

NCT07241299

Université de Reims Champagne-Ardenne

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.